National Oncology Drugs Management System
National Cancer Control Programme (NCCP), Health Service Executive
Data collection commenced September 2012. Reporting process commenced April 2013.
To coordinate and manage the use of cancer drugs nationally. The full statement of purpose can be found at this link [PDF].
National – there are 26 acute public hospitals nationally that provide cancer drug services and participate in the National Cancer Drug Management Programme.
Data collection is on a continuous basis to enable a funding mechanism.
The National Cancer Drug Management Programme coordinates and manages the use of cancer drugs nationally. A key component of the programme is the Oncology Drugs Management System, which is operated by the Primary Care Reimbursement Service (PCRS) on behalf of NCCP. This online based system is designed to collect information from hospitals on an ongoing basis in relation to patient demographic data, cancer drug use and cancer drug spending.
National Cancer Control Programme, Primary Care Reimbursement Service, CPU
Patient information includes: name; date of birth; gender; address; contact details (if available); PPS or medical card number or long term illness card number (if available).
Yes, but not available online.
PPSN.
Place of residence.
Hospital staff input the required data into an online system. The system is managed and operated by PCRS. Anonymised aggregated reports from the system are provided by PCRS to NCCP.
Data is collected monthly.
ICD-10.
21,030 claims submitted – 2021
17,019 claims submitted – 2020
15,640 claims submitted - 2019
Hospitals update data on an ongoing basis, as cancer drugs are dispensed. Ongoing reports provided to NCCP by PCRS.
Monthly HSE Performance Report, NCCP annual report, data requests.
No.